Hey Tim! It's been a while buddy. Hope you and your family are doing well, it's good to see you posting again.
ACAD has certainly been a poor investment for me, but I still believe the drug is ahead of it's time. My son still takes it and the insurance companies seem to be more willing to approve it off label.
I don't hold out much hope for the investment, but I do believe that at the end of the day the drug helps me son with negative symptoms of schizophrenia, and I hold out hope for those who suffer will see the drug approved for that indication.
I just hope ACAD gets to $29, my break even, so I can get out. :)